BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25616154)

  • 1. Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study.
    Otaegui D; Masdeu C; Aldaba E; Vara Y; Zubia A; San Sebastian E; Alcalá M; Villafruela S; Cossío FP; Rodriguez-Gascón A
    Biomed Chromatogr; 2015 Aug; 29(8):1249-58. PubMed ID: 25616154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of Kendine 91, a novel histone deacetylase inhibitor, in mice plasma and tissues: application to a pharmacokinetic study.
    Otaegui D; Rodríguez-Gascón A; Zubia A; Cossío FP; Pedraz JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):109-16. PubMed ID: 18583203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative determination and pharmacokinetic study of aurantio-obtusin in rat plasma by liquid chromatography-mass spectrometry.
    Zhang N; Dong N; Pang L; Xu H; Ji H
    J Chromatogr Sci; 2014 Oct; 52(9):1059-64. PubMed ID: 24149003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly sensitive method for the quantification of fludrocortisone in human plasma using ultra-high-performance liquid chromatography tandem mass spectrometry and its pharmacokinetic application.
    Banda J; Lakshmanan R; Vvs SP; Gudla SP; Prudhivi R
    Biomed Chromatogr; 2015 Aug; 29(8):1213-9. PubMed ID: 25611194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of genkwanin in rat plasma by liquid chromatography-tandem mass spectrometry: application to a bioavailability study.
    Song Y; Zhang S; Liu H; Jin X
    J Pharm Biomed Anal; 2013 Oct; 84():129-34. PubMed ID: 23831487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination and pharmacokinetic study of the novel anti-tumor candidate drug DG-7 in rat plasma by liquid chromatography-tandem mass spectrometry.
    Li J; Liu DD; Ke Y; Guo F; Ding XM; Wang SL; Chen Y; Liu HM; Su YQ; Nan YY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():14-8. PubMed ID: 24780702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid and sensitive LC-MS/MS method for quantification of 3,29-dibenzoyl rarounitriol in rat plasma: application to a pharmacokinetic study.
    Zhao C; Zhang N; Chen B; Song Y; Zhu N; Zhao L; Liu C; Meng X
    Biomed Chromatogr; 2015 Aug; 29(8):1229-34. PubMed ID: 25611485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of cefadroxil in rat plasma and urine using LC-MS/MS and its application to pharmacokinetic and urinary excretion studies.
    Jin HE; Kim IB; Kim YC; Cho KH; Maeng HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():103-10. PubMed ID: 24412692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
    Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
    J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma.
    Li W; Rettig J; Jiang X; Francisco DT; Naidong W
    Biomed Chromatogr; 2006 Nov; 20(11):1242-51. PubMed ID: 16838265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of HS270, a new histone deacetylase inhibitor, in rat plasma by LC-MS/MS--application to a preclinical pharmacokinetic study.
    Zhong GP; Chen JY; Bi HC; Qin XL; Dai CL; Liu J; Chen X; Zeng GX; Huang ZY; Huang M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3452-8. PubMed ID: 21983196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of CUDC-101 in rat plasma by liquid chromatography mass spectrometry and its application to a pharmacokinetic study.
    Zhang Q; Wen C; Xiang Z; Ma J; Wang X
    J Pharm Biomed Anal; 2014 Mar; 90():134-8. PubMed ID: 24366214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sensitive LC-MS/MS method for determination of megestrol acetate in human plasma: application to a human pharmacokinetic study.
    Seo JH; Park JS; Jo MH; Park MS; Ryu JH; Cho YW; Shim WS; Noh GJ; Lee KT
    Biomed Chromatogr; 2013 Apr; 27(4):409-15. PubMed ID: 22961730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a UPLC-MS/MS method for the determination of cucurbitacin B in rat plasma and application to a pharmacokinetic study.
    Zhao W; Xu D; Yan W; Wang Y; Zhang N
    Biomed Chromatogr; 2016 Apr; 30(4):503-7. PubMed ID: 26207321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a LC-ESI-MS/MS method for the determination of swertiamarin in rat plasma and its application in pharmacokinetics.
    Li HL; Peng XJ; He JC; Feng EF; Xu GL; Rao GX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1653-8. PubMed ID: 21531636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel UPLC-MS/MS method for sensitive quantitation of boldine in plasma, a potential anti-inflammatory agent: application to a pharmacokinetic study in rats.
    Zeng RJ; Li Y; Chen JZ; Chou GX; Gao Y; Shao JW; Jia L; Wu SD; Wu SS
    Biomed Chromatogr; 2015 Mar; 29(3):459-64. PubMed ID: 25065486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of vorinostat and its main metabolites in plasma and intracellular vorinostat in PBMCs by liquid chromatography coupled to tandem mass spectrometry and its relation to histone deacetylase activity in human blood.
    Liu L; Detering JC; Milde T; Haefeli WE; Witt O; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():212-21. PubMed ID: 24636840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of ultra high performance liquid chromatography-mass spectrometry method for LBH589 in mouse plasma and tissues.
    Estella-Hermoso de Mendoza A; Imbuluzqueta I; Campanero MA; Gonzalez D; Vilas-Zornoza A; Agirre X; Lana H; Abizanda G; Prosper F; Blanco-Prieto MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3490-6. PubMed ID: 21983199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.